3 ms·
> What I was saying was that those drugs have been proving effective regardless of mutation status. I don't believe this is the case in general. Indeed, all c
by pfdietz 4y ago
> What I was saying was that those drugs have been proving effective regardless of mutation status.
I don't believe this is the case in general. Indeed, all cancer drugs fail sometimes, and there has to be something different about the cancers they fail on. If not the mutation status, then what?
- dominotw 4y agoI am not quite sure how to respond to 'I don't believe' response. Even FDA is approving these mutation targeting drugs without mutation status. Niraparib was approved for Ovarian Cancer even if you don't have HRD mutations. Approval was based on NOVA trial, you can lookup the details. I am not saying there isn't any connection, what I am saying is it not really well understood or clearcut as mutation x = drug y that general public believes about these drugs.